Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal ion chelation in the microbial environment is a biological mechanism by which microorganisms produce and secrete chelating agents (such as siderophores and other organic ligands) to bind, solubilize, and acquire essential metal ions like iron, zinc, and manganese from their surroundings[1][5]. This strategy helps microbes survive in low-metal environments or toxic heavy metal conditions by mobilizing nutrients and facilitating detoxification[1][4][5]. Siderophores are a prominent example: these molecules form strong complexes with ferric iron, increasing bioavailability, and enabling iron import into microbial cells[1][5]. Chelation is fundamental to microbial nutrition, pathogenesis (including infection), and environmental heavy metal bioremediation. Drugs targeting this process (usually synthetic chelators) act as competitive binders to deprive microbes of essential metals, thus serving therapeutic and environmental roles[3].
Competitive metal sequestration: drugs or agents bind metal ions, limiting their microbial uptake; Mimicry of nutritional immunity: restricting bioavailable metals to inhibit pathogen growth
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal ion chelation mechanism.